Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer
- 25 January 2020
- journal article
- research article
- Published by Elsevier BV in Endocrine
- Vol. 107 (2), 299-304
- https://doi.org/10.1016/j.ijrobp.2020.01.010
Abstract
No abstract availableKeywords
Funding Information
- Kirsten and Freddy Johansens
- National Cancer Institute (P30 CA 134274-04)
This publication has 29 references indexed in Scilit:
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?Endocrine, 2013
- Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Carcinoma: Final Results of Phase III Randomized TrialEndocrine, 2011
- 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized TrialEndocrine, 2011
- The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995Radiotherapy and Oncology, 2010
- A New Method for Synthesizing Radiation Dose–Response Data From Multiple Trials Applied to Prostate CancerEndocrine, 2010
- Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate CancerEndocrine, 2008
- Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate CancerJournal of Clinical Oncology, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- A re-analysis of available dose-response and time-dose data in Hodgkin's diseaseRadiotherapy and Oncology, 1994
- An updated dose-response analysis in Hodgkin's diseaseRadiotherapy and Oncology, 1992